For everyone else, GHK-Cu is one of the safest and most accessible entry points into peptide therapy
Our team runs comprehensive lab panels, identifies the right combination of therapies for your needs, ensures pharmaceutical-grade sourcing and dosing accuracy, and monitors your progress over time with regular follow-ups
Foam or bubbles Some foaming during reconstitution is normal and resolves as the solution settles
Commercial payers: Most require verification before the first infusion
Start low and slow for example, two nights per week for the first two weeks and increase frequency as tolerance builds
July 23, 2026: Pharmacy Compounding Advisory Committee meeting The FDA has scheduled a Pharmacy Compounding Advisory Committee (PCAC) meeting for July 23, 2026 to evaluate BPC-157 and TB-500 (free base and acetate forms), along with KPV and MOTs-C